You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

CLINICAL TRIALS PROFILE FOR TRETINOIN MICROSPHERE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Tretinoin Microsphere

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00907257 ↗ A Study of Different Use Regimens Using Two Acne Treatments Completed Bausch Health Americas, Inc. Phase 4 2009-02-01 A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
NCT00907257 ↗ A Study of Different Use Regimens Using Two Acne Treatments Completed Valeant Pharmaceuticals International, Inc. Phase 4 2009-02-01 A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
NCT00939133 ↗ Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin Completed Johnson & Johnson Phase 4 2009-07-01 The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
NCT00939133 ↗ Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin Completed Dermatrials Research Phase 4 2009-07-01 The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
NCT01135069 ↗ Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo Completed Spear Pharmaceuticals Phase 3 2009-10-01 The objective will be to assess clinical bioequivalence of 0.1% Retin-A Micro® Gel and Spear Pharmaceutical's generic 0.1% Tretinoin Microsphere Gel with a placebo arm.
NCT01243450 ↗ Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo Completed Spear Pharmaceuticals Phase 3 2009-10-01 The objective will be to assess clinical bioequivalence of 0.1% Retin-A Micro® Gel and Spear Pharmaceutical's generic 0.1% Tretinoin Microsphere Gel with a placebo arm.
NCT01522456 ↗ Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel Completed Galderma Laboratories, L.P. Phase 4 2012-04-01 To compare the tolerability of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% to Retin-A Micro® (tretinoin gel) microsphere when used by subjects with acne vulgaris for 3 weeks in terms of local tolerability parameters (erythema, dryness, scaling, stinging/burning) and preference.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tretinoin Microsphere

Condition Name

Condition Name for Tretinoin Microsphere
Intervention Trials
Acne 3
Acne Vulgaris 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tretinoin Microsphere
Intervention Trials
Acne Vulgaris 3
Recurrence 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tretinoin Microsphere

Trials by Country

Trials by Country for Tretinoin Microsphere
Location Trials
United States 14
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tretinoin Microsphere
Location Trials
Texas 2
Florida 2
North Carolina 1
New Jersey 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tretinoin Microsphere

Clinical Trial Phase

Clinical Trial Phase for Tretinoin Microsphere
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tretinoin Microsphere
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tretinoin Microsphere

Sponsor Name

Sponsor Name for Tretinoin Microsphere
Sponsor Trials
Spear Pharmaceuticals 2
Galderma Laboratories, L.P. 1
Taro Pharmaceuticals USA 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tretinoin Microsphere
Sponsor Trials
Industry 7
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Tretinoin Microsphere: Clinical Trials, Market Analysis, and Projections

Introduction to Tretinoin Microsphere

Tretinoin microsphere formulations have revolutionized the treatment of acne and other skin conditions by offering improved efficacy, reduced irritation, and enhanced stability. Here, we delve into the clinical trials, market analysis, and future projections for this innovative drug delivery system.

Clinical Trials and Efficacy

Reduction in Acne Lesions

Clinical trials have consistently shown that tretinoin microsphere gel (TMG) is highly effective in reducing both inflammatory and noninflammatory acne lesions. A meta-analysis of three randomized, double-blind, vehicle-controlled studies involving 629 patients demonstrated that TMG 0.04% applied once nightly significantly reduced acne lesions over a 12-week period compared to the vehicle gel[3].

Skin Hydration and Barrier Function

The novel lotion formulation of tretinoin microspheres has been associated with rapid increases in skin hydration and decreases in trans-epidermal water loss (TEWL), a key measure of skin barrier function. This is particularly beneficial for acne treatment, as a well-functioning skin barrier is crucial for re-establishing healthy skin[1].

Improved Tolerability

Tretinoin microsphere formulations are designed to reduce irritation, a common side effect of traditional tretinoin products. Studies have shown that these formulations result in fewer adverse events such as erythema, peeling, and dryness, making them more tolerable for patients[3].

Mechanism of Action

Microsphere Delivery System

The microsphere delivery system encapsulates tretinoin in porous, polymeric microspheres that release the drug gradually. This system enhances drug stability and reduces photodegradation, which is a significant issue with traditional tretinoin formulations. For instance, tretinoin in microsphere formulations remains stable even under exposure to fluorescent light or simulated solar UV irradiation, unlike traditional gels which degrade significantly under similar conditions[1][4].

Molecular Interactions

Research has shown that tretinoin interacts with the polymeric matrix of the microspheres through hydrogen bonding, which is crucial for the controlled release of the drug. This interaction ensures that tretinoin is released slowly, improving its efficacy and reducing side effects[4].

Market Analysis

Global Market Size and Growth

The global tretinoin market, which includes microsphere formulations, is projected to grow significantly. As of 2024, the market size was valued at USD 2.5 billion and is expected to reach USD 7.5 billion by 2031, growing at a CAGR of 10.1% during the forecast period[5].

Regional Market Dynamics

North America and Europe are currently the largest markets for tretinoin, driven by the high prevalence of acne vulgaris and the approval of tretinoin products in these regions. The Asia-Pacific region, particularly Japan, is also expected to provide significant market opportunities due to the presence of major pharmaceutical companies like Chugai[2][5].

Distribution Channels

Tretinoin products, including microsphere formulations, are available through various distribution channels such as pharmacies, drugstores, prescription dispensing by healthcare professionals, and online retail platforms. The growing trend of online retail is expected to further boost the market[5].

Market Drivers

Acne Therapy

The primary driver of the tretinoin market is the treatment of acne vulgaris. The high demand for effective acne treatments and the proven efficacy of tretinoin microsphere formulations in reducing acne lesions contribute significantly to market growth[5].

Anti-Aging Features

Tretinoin's reputation as an anti-aging agent also drives market demand. Its ability to reduce fine lines, wrinkles, and other signs of aging makes it a popular ingredient in skincare formulations[5].

Medical Conditions

Tretinoin is used to treat various dermatological conditions, including psoriasis and certain types of skin cancer. The medical necessity of these uses further fuels the demand for tretinoin products[5].

Increasing Awareness of Skin Health

Rising consumer awareness of the importance of skin care and maintaining healthy skin is another key driver. Consumers are increasingly seeking products with ingredients like tretinoin that offer skin-renewing effects[5].

Market Challenges

Side Effects

Despite its benefits, tretinoin is associated with side effects, particularly when used in oral forms for conditions like leukemia. These side effects, such as leukocytosis, retinoic acid syndrome, and others, can inhibit market growth[2].

Photodegradation

Traditional tretinoin formulations are prone to photodegradation, which can reduce their efficacy. However, the microsphere delivery system has significantly mitigated this issue[1].

Future Projections

Innovation in Formulations

Ongoing research and development in dermatology and skincare are expected to drive innovation in tretinoin formulations. New products and formulations will continue to enhance the patient experience and expand the market[5].

Patient Preference for Topical Treatments

Patients' preference for topical treatments over systemic therapies will continue to drive the demand for tretinoin microsphere formulations. These formulations offer the convenience and efficacy that patients seek[5].

Recommendations from Dermatologists

Dermatologists' recommendations play a crucial role in consumer awareness and demand. As more dermatologists recommend tretinoin microsphere formulations, the market is expected to grow further[5].

Key Takeaways

  • Clinical Efficacy: Tretinoin microsphere formulations are highly effective in reducing acne lesions and improving skin hydration.
  • Market Growth: The global tretinoin market is projected to grow at a CAGR of 10.1% from 2024 to 2031.
  • Regional Dynamics: North America and Europe are the largest markets, with significant opportunities in the Asia-Pacific region.
  • Market Drivers: Acne therapy, anti-aging features, and increasing awareness of skin health are key drivers.
  • Innovation: Ongoing research and development will continue to enhance tretinoin formulations.

FAQs

What are the primary benefits of tretinoin microsphere formulations?

Tretinoin microsphere formulations offer improved efficacy in reducing acne lesions, enhanced skin hydration, reduced irritation, and improved stability against photodegradation.

Which regions are the largest markets for tretinoin?

North America and Europe are currently the largest markets for tretinoin, with significant growth expected in the Asia-Pacific region.

What are the common side effects associated with tretinoin microsphere formulations?

Common side effects include erythema, peeling, and dryness, which are mostly mild and occur in a lower percentage of patients compared to traditional tretinoin formulations.

How do tretinoin microspheres interact with the skin?

Tretinoin microspheres interact with the skin through a controlled release mechanism, enhancing skin hydration and reducing trans-epidermal water loss, thus supporting the skin barrier function.

What is the projected market size of the global tretinoin market by 2031?

The global tretinoin market is projected to reach USD 7.5 billion by 2031, growing at a CAGR of 10.1% from 2024 to 2031.

Sources

  1. Matrix Revisited: Innovative Approach for Tretinoin - JDDonline
  2. Tretinoin Market Size, Industry Share | Forecast 2032 - Fortune Business Insights
  3. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis - PubMed
  4. Interaction Studies of Tretinoin with Microspheres in Tretinoin ... - FDA
  5. Tretinoin Market Size, Share, Scope, Trends And Forecast - Verified Market Research
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.